Peripheral Vascular Devices | Market Insights | Japan | 2020
The Japanese PV device market will see modest growth through 2028, driven primarily by the expanding PAD population and the availability of new premium-priced products, such as DES and DCBs, that are backed by strong clinical data. However, market revenues will be hindered by ASP declines caused by biennial reimbursement cuts by the MHLW over the forecast period.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in Japan across a 10-year period.
